Search research articles
Contact Us
Filters
Showing results (1-10 of 6) with videos related to
Page
of 1
Sort By:
Optics Express
|
July 8, 2009
Ultimate spatial resolution with Diffuse Optical Tomography
Leila Azizi, Katarzyna Zarychta, Dominique Ettori, et al.
Optics Express
|
August 20, 2010
Time-resolved diffusing wave spectroscopy with a CCD camera
Katarzyna Zarychta, Eric Tinet, Leila Azizi, et al.
Cancer Immunology Research
|
February 13, 2019
Autologous Lymphocyte Infusion Supports Tumor Antigen Vaccine-Induced Immunity in Autologous Stem Cell Transplant for Multiple Myeloma
Adam D Cohen, Nikoletta Lendvai, Sarah Nataraj, et al.
Blood Advances
|
January 4, 2018
A phase 2 study of panobinostat with lenalidomide and weekly dexamethasone in myeloma
Ajai Chari, Hearn J Cho, Amishi Dhadwal, et al.
American Journal of Hematology
|
December 10, 2019
Recapturing disease response: A phase 2 study of carfilzomib 56 mg/m<sup>2</sup> in patients with relapsed or refractory multiple myeloma who have progressed on carfilzomib 27 mg/m<sup>2</sup>
Kevin Barley, Larysa Sanchez, Hearn J Cho, et al.
Leukemia & Lymphoma
|
August 20, 2020
A phase II study of pomalidomide, daily oral cyclophosphamide, and dexamethasone in relapsed/refractory multiple myeloma
Oliver Van Oekelen, Samir Parekh, Hearn J Cho, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 6) with videos related to
Sort By:
Page
of 1
Optics Express
|
July 8, 2009
Ultimate spatial resolution with Diffuse Optical Tomography
Leila Azizi, Katarzyna Zarychta, Dominique Ettori, et al.
Optics Express
|
August 20, 2010
Time-resolved diffusing wave spectroscopy with a CCD camera
Katarzyna Zarychta, Eric Tinet, Leila Azizi, et al.
Cancer Immunology Research
|
February 13, 2019
Autologous Lymphocyte Infusion Supports Tumor Antigen Vaccine-Induced Immunity in Autologous Stem Cell Transplant for Multiple Myeloma
Adam D Cohen, Nikoletta Lendvai, Sarah Nataraj, et al.
Blood Advances
|
January 4, 2018
A phase 2 study of panobinostat with lenalidomide and weekly dexamethasone in myeloma
Ajai Chari, Hearn J Cho, Amishi Dhadwal, et al.
American Journal of Hematology
|
December 10, 2019
Recapturing disease response: A phase 2 study of carfilzomib 56 mg/m<sup>2</sup> in patients with relapsed or refractory multiple myeloma who have progressed on carfilzomib 27 mg/m<sup>2</sup>
Kevin Barley, Larysa Sanchez, Hearn J Cho, et al.
Leukemia & Lymphoma
|
August 20, 2020
A phase II study of pomalidomide, daily oral cyclophosphamide, and dexamethasone in relapsed/refractory multiple myeloma
Oliver Van Oekelen, Samir Parekh, Hearn J Cho, et al.
Page
of 1